Joachim Pfannschmidt

7PUBLICATIONS
11CO-AUTHORS
Oncology and carcinogenesis not elsewhere classifiedPredictive and prognostic markersMolecular targetsCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 16, 2023
Extracapsular extension of pN2 lymph node metastases is not prognostically significant in surgically resected patients with non-small cell lung cancer.

Christin Müller, Samantha Taber, Joachim Pfannschmidt

|Jul 14, 2023
Integrated Clinical, Molecular and Immunological Characterization of Pulmonary Sarcomatoid Carcinomas Reveals an Immune Escape Mechanism That May Influence Therapeutic Strategies.

Susann Stephan-Falkenau, Anna Streubel, Thomas Mairinger

|Nov 01, 2022
Value of 18F FDG-PET/CT parameters on long term follow-up for patients with non-small cell lung cancer.

Mohammed Zoair, Samantha Taber, Roland Bittner

|Oct 27, 2022
Landscape of Genomic Alterations and PD-L1 Expression in Early-Stage Non-Small-Cell Lung Cancer (NSCLC)-A Single Center, Retrospective Observational Study.

Susann Stephan-Falkenau, Anna Streubel, Thomas Mairinger

|Feb 28, 2022
Implication of FDG-PET/CT in patients with potentially operable colorectal lung metastases.

Anton Uporov, Samantha Taber, Lope Estèvez Schwarz

|Apr 30, 2021
Validation of the T Descriptor (TNM-8) in T3N0 Non-Small-Cell Lung Cancer Patients; a Bicentric Cohort Analysis with Arguments for Redefinition.

Philip Baum, Samantha Taber, Stella Erdmann

Pageof 2

Frequent Collaborators

2 joint publications

Torsten Bauer

2 joint publications

Michael Wessolly

1 joint publications

Philip Baum

1 joint publications

Stella Erdmann